Summary of Purpose
The Ongoing Telmisartan Alone and in combination wiht Ramipril Global Endpoint trial (ONTARGET): The primary objectives are to determine if (a) telmisartan 80mg daily and ramipril 10mg daily combination therapy is more effective in reducing the composite endpoint of Cardiovascular Death (CV) death, Myocardial infarction (MI), stroke or hospitalization for Congestive Heart Failure (CHF) compared with ramipril 10mg...Read More →
The following dates are available for this trial. Trial information last updated on 13 May 2014.
|1 Nov 2001||9 Sep 2005||1 Jun 2008||Unavailable||1 May 2014||15 Jun 2009|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Purpose: Prevention
- Intervention: Parallel Assignment
Ingrid Copland ONTARGET/TRANSCEND Research Coordinator Population Health Research Institute Hamilton General Hospital McMaster Clinic, Rm 355 237 Barton St. East Hamilton, ON L8L 2X2, Canada Tel: 905-527-4322 ext. 44520 Email: Ingrid@email@example.com